Author:
Sulzyc-Bielicka Violetta,Domagala Pawel,Bielicki Dariusz,Safranow Krzysztof,Domagala Wenancjusz
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference47 articles.
1. N.H. Segal, L.B. Saltz, Is adjuvant therapy for stage II colon cancer worthwhile, and for whom? Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 422–423 (2008)
2. D.B. Longley, D.P. Harkin, P.G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330–338 (2003)
3. H.H. Backus, D.F. Dukers, C.J. van Groeningen, W. Vos, E. Bloemena, D. Wouters, J.M. van Riel, K. Smid, G. Giaccone, H.M. Pinedo, G.J. Peters, 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. Ann. Oncol. 12, 209–216 (2001)
4. B.L. Adamsen, K.L. Kravik, O.P. Clausen, P.M. De Angelis, Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int. J. Oncol. 31, 1491–1500 (2007)
5. B. Vincenzi, D. Santini, G. Tonini, Thymidylate synthase expression in colorectal cancer: the never-ending story. J. Clin. Oncol. 23, 2108 (2005). author reply 2108–9
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献